These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 10915030

  • 1. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.
    Lipworth BJ, Jackson CM.
    Drug Saf; 2000 Jul; 23(1):11-33. PubMed ID: 10915030
    [Abstract] [Full Text] [Related]

  • 2. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT, Richards DH.
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [Abstract] [Full Text] [Related]

  • 3. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations.
    Gulliver T, Morton R, Eid N.
    Paediatr Drugs; 2007 Nov; 9(3):185-94. PubMed ID: 17523699
    [Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of treatments for allergic rhinitis in children.
    Baena-Cagnani CE.
    Drug Saf; 2004 Nov; 27(12):883-98. PubMed ID: 15366976
    [Abstract] [Full Text] [Related]

  • 5. Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma.
    Zeidler M, Corren J.
    Treat Respir Med; 2004 Nov; 3(1):35-44. PubMed ID: 15174892
    [Abstract] [Full Text] [Related]

  • 6. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis.
    Blaiss MS.
    Allergy Asthma Proc; 2011 Nov; 32(6):413-8. PubMed ID: 22221434
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of corticosteroids in bronchial asthma.
    Lipworth BJ.
    Pharmacol Ther; 1993 Nov; 58(2):173-209. PubMed ID: 8415878
    [Abstract] [Full Text] [Related]

  • 8. Extra-fine particle inhaled corticosteroids, pharma-cokinetics and systemic activity in children with asthma.
    Wolthers OD.
    Pediatr Allergy Immunol; 2016 Feb; 27(1):13-21. PubMed ID: 26360937
    [Abstract] [Full Text] [Related]

  • 9. Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma.
    Menzies D, Nair A, Hopkinson P, McFarlane L, Lipworth BJ.
    Allergy; 2007 Jun; 62(6):661-7. PubMed ID: 17508971
    [Abstract] [Full Text] [Related]

  • 10. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
    Derendorf H, Meltzer EO.
    Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
    [Abstract] [Full Text] [Related]

  • 11. Intranasal corticosteroids and adrenal suppression.
    Bruni FM, De Luca G, Venturoli V, Boner AL.
    Neuroimmunomodulation; 2009 Oct; 16(5):353-62. PubMed ID: 19571596
    [Abstract] [Full Text] [Related]

  • 12. Safety of intranasal corticosteroids in acute rhinosinusitis.
    Demoly P.
    Am J Otolaryngol; 2008 Oct; 29(6):403-13. PubMed ID: 19144302
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy and safety of inhaled corticosteroids in asthma.
    Jackson LD, Polygenis D, McIvor RA, Worthington I.
    Can J Clin Pharmacol; 1999 Oct; 6(1):26-37. PubMed ID: 10465863
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of intranasal corticosteroids.
    Szefler SJ.
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S26-31. PubMed ID: 11449203
    [Abstract] [Full Text] [Related]

  • 15. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L, Prietsch SO, Ducharme FM.
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [Abstract] [Full Text] [Related]

  • 16. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
    Harrison LI.
    J Aerosol Med; 2002 Dec; 15(4):401-6. PubMed ID: 12581506
    [Abstract] [Full Text] [Related]

  • 17. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology.
    Acerbi D, Brambilla G, Kottakis I.
    Pulm Pharmacol Ther; 2007 Dec; 20(3):290-303. PubMed ID: 16890465
    [Abstract] [Full Text] [Related]

  • 18. Assessing the effect of intranasal steroids on growth.
    Pedersen S.
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S40-4. PubMed ID: 11449205
    [Abstract] [Full Text] [Related]

  • 19. Aseptic femoral head necrosis in a patient receiving long term courses of inhaled and intranasal corticosteroids.
    Karkoulias K, Charokopos N, Kaparianos A, Sampsonas F, Tsiamita M, Spiropoulos K.
    Tuberk Toraks; 2007 Jul; 55(2):182-5. PubMed ID: 17602347
    [Abstract] [Full Text] [Related]

  • 20. New intranasal formulations for the treatment of allergic rhinitis.
    Meltzer EO, Bensch GW, Storms WW.
    Allergy Asthma Proc; 2014 Jul; 35 Suppl 1():S11-9. PubMed ID: 25582157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.